Early Parkinson's Disease Monotherapy With CVN424

Clinical trial NCT06006247 · COMPLETED

Trial details

NCT number: NCT06006247
Sponsor: Cerevance Beta, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2023-09-11
Primary completion: 2025-01-30
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.